Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate.

The arsenic (+3 oxidation state) methyltransferase (As3mt) gene encodes a 43 kDa protein that catalyzes methylation of inorganic arsenic. Altered expression of AS3MT in cultured human cells controls arsenic methylation phenotypes, suggesting a critical role in arsenic metabolism. Because methylated arsenicals mediate some toxic or carcinogenic effects linked to inorganic arsenic exposure, studies of the fate and effects of arsenicals in mice which cannot methylate arsenic could be instructive. This study compared retention and distribution of arsenic in As3mt knockout mice and in wild-type C57BL/6 mice in which expression of the As3mt gene is normal. Male and female mice of either genotype received an oral dose of 0.5 mg of arsenic as arsenate per kg containing [(73)As]-arsenate. Mice were radioassayed for up to 96 h after dosing; tissues were collected at 2 and 24 h after dosing. At 2 and 24 h after dosing, livers of As3mt knockouts contained a greater proportion of inorganic and monomethylated arsenic than did livers of C57BL/6 mice. A similar predominance of inorganic and monomethylated arsenic was found in the urine of As3mt knockouts. At 24 h after dosing, As3mt knockouts retained significantly higher percentages of arsenic dose in liver, kidneys, urinary bladder, lungs, heart, and carcass than did C57BL/6 mice. Whole body clearance of [(73)As] in As3mt knockouts was substantially slower than in C57BL/6 mice. At 24 h after dosing, As3mt knockouts retained about 50% and C57BL/6 mice about 6% of the dose. After 96 h, As3mt knockouts retained about 20% and C57BL/6 mice retained less than 2% of the dose. These data confirm a central role for As3mt in the metabolism of inorganic arsenic and indicate that phenotypes for arsenic retention and distribution are markedly affected by the null genotype for arsenic methylation, indicating a close linkage between the metabolism and retention of arsenicals.

[1]  Jie Liu,et al.  Toxicokinetic and genomic analysis of chronic arsenic exposure in multidrug-resistance mdr1a/1b(−/−) double knockout mice , 2004, Molecular and Cellular Biochemistry.

[2]  E. Marafante,et al.  Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit. , 1987, Toxicology letters.

[3]  Mark R. Witkowski,et al.  Dimethylthioarsinic anhydride: a standard for arsenic speciation. , 2007, Analytica chimica acta.

[4]  S. Waters,et al.  Arsenic (+3 oxidation state) methyltransferase and the inorganic arsenic methylation phenotype. , 2005, Toxicology and applied pharmacology.

[5]  V. Devesa,et al.  Tissue dosimetry, metabolism and excretion of pentavalent and trivalent dimethylated arsenic in mice after oral administration. , 2005, Toxicology and applied pharmacology.

[6]  J. Ward,et al.  Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. , 2003, Toxicology and applied pharmacology.

[7]  J. Creed,et al.  Exploring the in vitro formation of trimethylarsine sulfide from dimethylthioarsinic acid in anaerobic microflora of mouse cecum using HPLC-ICP-MS and HPLC-ESI-MS. , 2009, Toxicology and applied pharmacology.

[8]  W. Goessler,et al.  Metabolism of Low-Dose Inorganic Arsenic in a Central European Population: Influence of Sex and Genetic Polymorphisms , 2007, Environmental health perspectives.

[9]  G. Schwedt,et al.  Separation of thio- and oxothioarsenates by capillary zone electrophoresis and ion chromatography , 1996 .

[10]  M. Vahter,et al.  Low-level arsenic excretion in breast milk of native Andean women exposed to high levels of arsenic in the drinking water , 1998, International archives of occupational and environmental health.

[11]  P. G. Reeves,et al.  AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. , 1993, The Journal of nutrition.

[12]  S. Waters,et al.  Elucidating the pathway for arsenic methylation. , 2004, Toxicology and applied pharmacology.

[13]  S. Waters,et al.  Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. , 2005, Toxicology and applied pharmacology.

[14]  M. Stýblo,et al.  In vitro methylation of inorganic arsenic in mouse intestinal cecum. , 1997, Toxicology and applied pharmacology.

[15]  M. Vahter.  Mechanisms of arsenic biotransformation. , 2002, Toxicology.

[16]  E. Marafante,et al.  The role of the methylation in the detoxication of arsenate in the rabbit. , 1985, Chemico-biological interactions.

[17]  Kevin M. Kubachka,et al.  In vitro biotransformation of dimethylarsinic acid and trimethylarsine oxide by anaerobic microflora of mouse cecum analyzed by HPLC-ICP-MS and HPLC-ESI-MS , 2009 .

[18]  E. Marafante,et al.  The effect of methyltransferase inhibition on the metabolism of [74As]arsenite in mice and rabbits. , 1984, Chemico-biological interactions.

[19]  Thomas J. Smith,et al.  Arsenic Methylation and Skin Cancer Risk in Southwestern Taiwan , 2003, Journal of occupational and environmental medicine.

[20]  M. Stýblo,et al.  shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells. , 2006, Chemical research in toxicology.

[21]  E. Kenyon,et al.  Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsinic acid in the mouse after intravenous administration. , 1998, Journal of toxicology and environmental health. Part A.

[22]  S. Fukushima,et al.  A comparative study of the sub-chronic toxic effects of three organic arsenical compounds on the urothelium in F344 rats; gender-based differences in response. , 2006, Toxicology and applied pharmacology.

[23]  Z. Gregus,et al.  Effect of selenite on the disposition of arsenate and arsenite in rats. , 2003, Toxicology.

[24]  E. Kenyon,et al.  Strain-dependent disposition of inorganic arsenic in the mouse. , 1999, Toxicology.

[25]  T. Gebel.  Arsenic methylation is a process of detoxification through accelerated excretion. , 2002, International journal of hygiene and environmental health.

[26]  C. Ferreccio,et al.  Profile of urinary arsenic metabolites during pregnancy. , 2003, Environmental health perspectives.

[27]  Y. Hsueh,et al.  Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. , 1998, Journal of toxicology and environmental health. Part A.

[28]  S. Waters,et al.  Arsenic (+3 Oxidation State) Methyltransferase and the Methylation of Arsenicals , 2007, Experimental biology and medicine.

[29]  A. Smith,et al.  Methylation study of a population environmentally exposed to arsenic in drinking water. , 1996, Environmental health perspectives.

[30]  V. Gladyshev,et al.  High-Throughput Identification of Catalytic Redox-Active Cysteine Residues , 2007, Science.

[31]  Jie Liu,et al.  Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[32]  W. Cullen,et al.  The metabolism of methylarsine oxide and sulfide , 1989 .

[33]  S. Hirano,et al.  Arsenic metabolism and thioarsenicals in hamsters and rats. , 2007, Chemical research in toxicology.

[34]  Mark R. Witkowski,et al.  Chromatographic separation and identification of products from the reaction of dimethylarsinic acid with hydrogen sulfide. , 2005, Chemical research in toxicology.

[35]  J. Boyer,et al.  Arsenic ( þ 3 Oxidation State) Methyltransferase and the Methylation of Arsenicals in the Invertebrate Chordate Ciona intestinalis , 2009 .

[36]  M. Vahter,et al.  Reduction and binding of arsenate in marmoset monkeys , 1985, Archives of Toxicology.

[37]  Ju-Hoon Lee,et al.  Comparative genomic analysis of the gut bacterium Bifidobacterium longum reveals loci susceptible to deletion during pure culture growth , 2008, BMC Genomics.

[38]  M. Vahter,et al.  Lack of methylation of inorganic arsenic in the chimpanzee. , 1995, Toxicology and applied pharmacology.

[39]  Thomas G. Chasteen,et al.  Microbial Methylation of Metalloids: Arsenic, Antimony, and Bismuth , 2002, Microbiology and Molecular Biology Reviews.

[40]  Jie Liu,et al.  Multidrug-resistance mdr1a/1b double knockout mice are more sensitive than wild type mice to acute arsenic toxicity, with higher arsenic accumulation in tissues. , 2002, Toxicology.